Conquering the Cancer Care Continuum
The Affordable Care Act (ACA), officially called the Patient Protection and Affordable Care Act, which began implementation in March 2010 and will not be fully implemented until 2018, has impacted oncology care in both positive and negative ways. This legislation provides opportunities for addressing disparities in cancer care, and it has the potential to expand access to care and improve services among vulnerable groups.
In 2010, Congress passed (and the President signed into law) comprehensive healthcare legislation called the Patient Protection and Affordable Care Act (PPACA), or as it is more commonly known, the Affordable Care Act (ACA). This legislation provides a health insurance exchange in which individuals and small businesses can purchase qualified health plans (QHPs).
We have been hearing about the Affordable Care Act (ACA) for quite a while. However, many are still confused as to what this law is trying to accomplish and how it will benefit various populations of patients across the United States. This fourth issue of Conquering the Cancer Care Continuum™ provides readers with a comprehensive overview of the ACA as seen from the eyes of an oncology nurse, an insurance payer, and a pharmacist.
Cure rates for children with cancer now exceed 80% in high-income countries (HIC), but several challenges remain.
The birth of the pediatric hematology/oncology specialty can be traced back to the early part of the 20th century, when pediatricians began describing hematologic abnormalities in infants and children.
There is nothing that pulls at my heart strings more than the sight of a young child dealing with a diagnosis of cancer. This issue of Conquering the Cancer Care Continuum™ focuses on pediatric cancer care, a challenging area of oncology management, but one in which amazing progress is being made.
Confusion over the rules governing drug compounding has been an issue for many years. However, concerns about the safety and quality of compounded sterile products (CSPs), spurred by an outbreak of fungal meningitis infections that occurred in October 2012, have led to a fundamental change in the regulatory framework.
Page 1 of 2
Results 1 - 10 of 18
Results 1 - 10 of 18